October 9, 2008 — Stool DNA testing is a new approach to screening for colorectal cancer, but it is an evolving technology. A study has found that the first-generation stool DNA test (SDT-1) is not ...
A study conducted by UCLA researchers indicates sending unsolicited stool test kits to people aged 45-49 is the most effective way to increase colon cancer screening. Photo by Tamas Soki/EPA ...
June 27, 2003 -- A monoclonal antibody stool test is highly predictive of the presence or absence of Helicobacter pylori infection in children, according to the results of a study published in the ...
Each year, close to 2 million people around the world are diagnosed with colorectal cancer and roughly 935,000 people die from it. Scientists say they have developed a new stool test that is more ...
Health insurance companies send all kinds of things in the mail: brochures about benefits, branded items such as coasters and duffel bags, and reminders to get certain health tests done. Some have ...
Medicare should cover a parasite poop test when medically necessary, usually when a person has symptoms of gastroenteritis or a history of exposure to a parasite. Laboratory technicians perform a ...
INDIANAPOLIS -- A study of more than 21,000 average risk patients at 186 sites across the U.S., led by Regenstrief Institute and Indiana University School of Medicine research scientist Thomas ...
CHICAGO (Reuters) - Using just a stool sample, doctors may now be able to detect colon and many other cancers of the digestive tract including stomach, pancreatic, bile duct and esophageal cancer, U.S ...
Please provide your email address to receive an email when new articles are posted on . Compared with the original Cologuard test approved by the FDA in 2014, the company’s next-generation test uses ...
VANCOUVER, British Columbia -- The novel multitarget stool RNA test (ColoSense) showed high sensitivity for detecting colorectal neoplasia among adults ages 45 and older, according to the phase III ...
NEW YORK (Reuters Health) - A simplified colorectal cancer screening test that detects tumor DNA in stool is an improvement over an earlier-generation assay, according to North American researchers.